vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and Ralliant Corp (RAL). Click either name above to swap in a different company.
Ralliant Corp is the larger business by last-quarter revenue ($529.1M vs $397.6M, roughly 1.3× Guardian Pharmacy Services, Inc.). Ralliant Corp runs the higher net margin — 7.5% vs 5.3%, a 2.3% gap on every dollar of revenue.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
GRDN vs RAL — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $397.6M | $529.1M |
| Net Profit | $20.9M | $39.9M |
| Gross Margin | 21.5% | 50.8% |
| Operating Margin | 7.7% | 9.8% |
| Net Margin | 5.3% | 7.5% |
| Revenue YoY | — | -0.5% |
| Net Profit YoY | — | -56.1% |
| EPS (diluted) | — | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $397.6M | — | ||
| Q3 25 | $377.4M | $529.1M | ||
| Q2 25 | $344.3M | $503.3M | ||
| Q1 25 | $329.3M | — | ||
| Q3 24 | $314.4M | $531.7M | ||
| Q2 24 | — | $533.7M |
| Q4 25 | $20.9M | — | ||
| Q3 25 | $9.8M | $39.9M | ||
| Q2 25 | $9.0M | $47.6M | ||
| Q1 25 | $9.4M | — | ||
| Q3 24 | $-122.0M | $90.9M | ||
| Q2 24 | — | $64.8M |
| Q4 25 | 21.5% | — | ||
| Q3 25 | 19.8% | 50.8% | ||
| Q2 25 | 19.8% | 49.3% | ||
| Q1 25 | 19.5% | — | ||
| Q3 24 | 19.4% | 52.6% | ||
| Q2 24 | — | 51.5% |
| Q4 25 | 7.7% | — | ||
| Q3 25 | 4.3% | 9.8% | ||
| Q2 25 | 3.7% | 11.7% | ||
| Q1 25 | 3.9% | — | ||
| Q3 24 | -33.3% | 20.9% | ||
| Q2 24 | — | 19.7% |
| Q4 25 | 5.3% | — | ||
| Q3 25 | 2.6% | 7.5% | ||
| Q2 25 | 2.6% | 9.5% | ||
| Q1 25 | 2.9% | — | ||
| Q3 24 | -38.8% | 17.1% | ||
| Q2 24 | — | 12.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | $0.35 | ||
| Q2 25 | — | $0.42 | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $0.81 | ||
| Q2 24 | — | $0.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $264.2M |
| Total DebtLower is stronger | $0 | $1.1B |
| Stockholders' EquityBook value | $217.9M | $3.0B |
| Total Assets | $412.7M | $5.3B |
| Debt / EquityLower = less leverage | 0.00× | 0.39× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.6M | — | ||
| Q3 25 | $36.5M | $264.2M | ||
| Q2 25 | $18.8M | $198.6M | ||
| Q1 25 | $14.0M | — | ||
| Q3 24 | $37.2M | — | ||
| Q2 24 | — | — |
| Q4 25 | $0 | — | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | — | ||
| Q3 24 | $34.3M | — | ||
| Q2 24 | — | — |
| Q4 25 | $217.9M | — | ||
| Q3 25 | $195.5M | $3.0B | ||
| Q2 25 | $179.7M | $3.0B | ||
| Q1 25 | $163.2M | — | ||
| Q3 24 | $133.9M | $4.0B | ||
| Q2 24 | — | $4.0B |
| Q4 25 | $412.7M | — | ||
| Q3 25 | $390.0M | $5.3B | ||
| Q2 25 | $356.3M | $5.2B | ||
| Q1 25 | $334.0M | — | ||
| Q3 24 | $348.0M | — | ||
| Q2 24 | — | — |
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | 0.38× | ||
| Q1 25 | — | — | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.6M | $138.6M |
| Free Cash FlowOCF − Capex | — | $126.6M |
| FCF MarginFCF / Revenue | — | 23.9% |
| Capex IntensityCapex / Revenue | — | 2.3% |
| Cash ConversionOCF / Net Profit | 1.65× | 3.47× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.6M | — | ||
| Q3 25 | $28.2M | $138.6M | ||
| Q2 25 | $19.9M | — | ||
| Q1 25 | $17.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $24.2M | $126.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 6.4% | 23.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.1% | 2.3% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | 1.65× | — | ||
| Q3 25 | 2.87× | 3.47× | ||
| Q2 25 | 2.21× | — | ||
| Q1 25 | 1.86× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRDN
Segment breakdown not available.
RAL
| Industrial Manufacturing | $111.1M | 21% |
| Defense And Space | $93.6M | 18% |
| Diversified Electronics | $91.0M | 17% |
| Test And Measurement | $76.8M | 15% |
| Communications | $60.7M | 11% |
| Semiconductors | $51.4M | 10% |
| Other Direct End Markets | $44.4M | 8% |
